# Executive Discovery Report

**Digital Healthcare Platform — Laboratory Management Discovery**
**Date:** 2026-07-16

## What Happened

We ran a complete, structured Discovery process — 12 stages, each with its
own checks — to map out the business and domain before any technical
architecture work begins. Because no real stakeholders were available to
interview in this session, the process ran in an explicitly-flagged
**"best industry practice" mode**: every finding is grounded in standard
laboratory/healthcare industry knowledge, not invented from nothing, but
also **not yet confirmed by anyone at this business**. Think of the result
as a well-organized, professionally-reasoned first draft — not a report of
established facts.

## What We Found

- A clear map of what the business likely does (20 capabilities) and the 4
  most important end-to-end flows (ordering a test, home sample collection,
  handling a rejected specimen, billing/insurance).
- A proposed answer to a question the project has had open since it began:
  which part of the platform is the "core" — the part where quality and
  investment matter most. Our answer: **the test-processing and
  result-verification step** — the moment a result becomes trustworthy.
  This is a proposal, not a decision.
- A full map of how the system's pieces should be organized (8 areas of
  responsibility) with clear rules for how they talk to each other.
- 3 places in the business rules that are "sensitive" and need extra
  safeguards — all clustered around verifying and releasing results, which
  matches common sense.
- 7 realistic ways AI could help (explaining results simply, flagging
  unusual patterns for a human to check, smarter search) — and, just as
  important, **1 idea we explicitly rejected**: letting AI approve normal
  results automatically without a person checking. That crosses a line this
  project already committed to never crossing.
- A short list of integration needs (lab devices, insurance company
  connections) and a security review of all of them.
- 22 specific open questions that only the business can answer — the most
  important one: **exactly who is allowed to sign off on a lab result**
  (a doctor-type role vs. a technician, depending on test type). This has
  direct patient-safety weight and should be answered before design work
  goes much further.

## What This Is Ready For

The *process* is completely done, and everything was double-checked for
internal consistency and security gaps — nothing contradicts the rules
this project already agreed to. On that basis, **software architecture
work can reasonably start** using this Discovery Book as its foundation.

**But:** because this ran without real stakeholder input, we're
recommending one thing before architecture work goes deep — a short review
pass where someone from the actual business confirms or corrects the
assumptions we logged (there's a full, organized list). That review is
low-effort compared to the Discovery work itself, and it's the difference
between building on a well-reasoned guess and building on the real
business.

## Bottom Line

Nothing is blocking the next phase. Two new architecture proposals are
ready for a yes/no/amend decision. One patient-safety-relevant question
deserves priority attention. Full detail is in the Discovery Book and
Completion Report; this page is the two-minute version.
